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Mycobacteria modulate host epigenetic machinery
by Rv1988 methylation of a non-tail arginine of
histone H3
Imtiyaz Yaseen1,2, Prabhjot Kaur3, Vinay Kumar Nandicoori3 & Sanjeev Khosla1
Mycobacteria are successful pathogens that modulate the host immune response through
unclear mechanisms. Here we show that Rv1988, a secreted mycobacterial protein, is a
functional methyltransferase that localizes to the host nucleus and interacts with chromatin.
Rv1988 methylates histone H3 at H3R42 and represses the genes involved in the first line of
defence against mycobacteria. H3R42me2, a non-tail histone modification, is present at the
entry and exit point of DNA in the nucleosome and not within the regulatory sites in the
N-terminal tail. Rv1988 deletion in Mycobacterium tuberculosis reduces bacterial survival in the
host, and experimental expression ofM. tuberculosis Rv1988 in non-pathogenicMycobacterium
smegmatis negatively affects the health of infected mice. Thus, Rv1988 is an important
mycobacterial virulence factor, which uses a non-canonical epigenetic mechanism to control
host cell transcription.
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T
he dynamic nature of chromatin organization allows for
reversible changes in eukaryotic gene expression. The
permissiveness of chromatin organization stems from
epigenetic modifications of the DNA itself or of the histone
proteins1,2. Each of the core histones can be modified at several
amino acids and for each amino acid more than one type of post-
translation modification is possible3,4. For example, histone H3 is
known to be modified at425 amino acids, and several lysines in
histone H3 are known to be acetylated or methylated5–7. This
variety of histone modifications and their correlation with gene
activity forms the basis of the histone code8. The complexity of
the histone code and its effect on gene expression is amplified by
the large numbers of effector enzymes that modify specific amino
acids of the histone proteins and the chromatin proteins that have
specificity for particular histone modifications9. With this
assortment of modifications and with each modification having
the potential to affect gene expression by a unique mechanism,
gene expression can no longer be considered as being in an ‘off’ or
‘on’ state.
A small pool of data suggests that the epigenetic circuits within
a mammalian cell also respond to bacterial infections10,11. There
are reports that show host cell signalling mediates changes in the
epigenetic modifications at specific gene loci in response to
bacterial infection12,13. Other reports have provided proof of
epigenetic modification by a bacterial protein. Legionella protein
RomA methylates the host Histone H3 at Lysine 14 (ref. 14) and
NuE, a protein from Chlamydia trachomatis, methylates both
H3 and H4 (ref. 15). We previously identified the mycobacterial
protein Rv2966c as a cytosine DNA methyltransferase that
methylates cytosine predominantly in non-CpG host cell DNA16.
Virulent species of mycobacteria interact and modulate their
host cell machinery at various subcellular levels and by different
mechanisms. Although several reports have documented changes
in the expression of host genes17, our literature survey could
not identify a study that had explored the possibility of a
mycobacterial factor influencing host gene expression through a
direct interaction with the host histone proteins. The aim of this
study is to identify a mycobacterial protein(s) that interacts with a
histone protein, modifies specific amino acids in it and influences
the expression of a gene subset in the host upon infection. We
show that the protein Rv1988, expressed only by virulent
mycobacterial species, interacts with histone H3, dimethylates
arginine at H3R42 and represses expression of genes that are
important for immune responses against mycobacterial infection.
Deletion of Rv1988 from the M. tuberculosis H37Rv strain
reduces bacterial survival during infection, whereas expression
of Rv1988 in non-virulent M. smegmatis provides a survival
advantage during infection of peritoneal macrophages. Rv1988
not only provides a survival advantage to M. smegmatis, but also
negatively affects the health of infected mice.
Results
Mycobacterial protein Rv1988 interacts with histone H3. To
identify mycobacterial proteins that could interact with histone
H3, recombinant 6X His-histone H3 purified from E.coli
was incubated with Mycobacterium bovis BCG lysate. The
mycobacterial proteins interacting with histone H3 were affinity
purified using Ni-NTA beads and electrophoresed on an
SDS–polyacrylamide gel electrophoresis (Supplementary Fig. 1).
Protein bands were cut out from the gel and identified by mass
spectrometry (MS). One of the mycobacterial proteins
identified in this analysis was Rv1988. Listed as a probable
methyltransferase in the Tuberculist database18, Rv1988 is
present in the pathogenic mycobacteria, M. tuberculosis and
M. bovis but absent in the non-pathogenic M. smegmatis.
To validate the interaction of Rv1988 with histone H3,
HEK293 cells were transfected with a pcDNA3.1 construct
containing the SFB (S-protein, FLAG, streptavidin-binding
peptide)-tagged Rv1988 gene. Forty-eight hours post transfection,
Rv1988 and its interacting partners were affinity purified using
Streptavidin beads from the protein lysate and analysed by
western blotting using histone H3 antibody. Vector alone
(pCDNA3.1) construct was used as a control. As can be seen
from Fig. 1a, affinity purification of SFB-Rv1988 from the
HEK293 protein lysate pulled down histone H3, indicating that
Rv1988 can indeed bind histone H3. Western blot probed with
FLAG antibody (FLAG peptide is part of the SFB tag) was used to
control pull-down efficiency (Fig. 1a, lower panel). Interaction
of Rv1988 with histone H3 was further confirmed by immuno-
precipitation (IP) of histone H3 from the protein lysate of
HEK293 cells transfected with SFB-Rv1988, followed by western
blotting and probing with FLAG antibody. As a control,
IP was also performed with IgG. FLAG-tagged SFB-Rv1988 was
co-immunoprecipitated with H3 but not with IgG (Fig. 1b).
IP efficiency was checked by probing the blots with antibody to
histone H3 (Fig. 1b, lower panel).
Rv1988 is a functional histone methyltransferase. Since Rv1988
was listed as a probable methyltransferase in the Tuberculist
database18, we decided to test whether Rv1988 could methylate
histone H3. In vitro methyltransferase assay was performed with
recombinant MBP-Rv1988 using recombinant histone H3
(purified from E.coli) as substrate and tritiated S-adenosyl
methionine (SAM) as methyl group donor and analysed by
autoradiography or scintillation counting. Tritiated methyl
groups were transferred to histone H3 in presence of
MBP-Rv1988 but not with MBP protein (Fig. 2a). Scintillation
quantitation also indicated that statistically higher amount of
tritiated methyl groups were transferred from tritiated SAM to
histone H3 in presence of MBP-Rv1988 than MBP, indicating
that Rv1988 can methylate histone H3 (Fig. 2b). Bioinformatic
comparison with the human proteome database indicated
that Rv1988 had some similarity with protein Arginine
methyltransferases (PRMTs). As members of PRMT family
are known to dimethylate arginine residues in histones19,
we performed in vitro histone methyltransferase assay on
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Figure 1 | Rv1988 interacts with histone H3. (a) Lysate of HEK293 cells,
transfected with SFB-Rv1988 or pcDNA3.1 (control) constructs and pulled
down with streptavidin beads was probed with antibodies as indicated.
In all, 5% of the whole-cell lysate was used as Input. Streptavidin pulls
down SFB-Rv1988. PD: pull down. (b) Immunoprecipitation was performed
with H3 antibody on SFB-Rv1988-transfected HEK293 cells and probed
with antibodies as indicated. IP was also done with IgG as a control. In all,
10% of the whole-cell lysate was used as Input. Anti-FLAG antibody
detected SFB-Rv1988.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9922
2 NATURE COMMUNICATIONS | 6:8922 | DOI: 10.1038/ncomms9922 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
recombinant histone H3 using cold SAM and after western
blotting, probed with a dimethyl arginine antibody (Abcam
ab413). Dimethyl arginine antibody detected histone H3 that was
incubated with MBP-Rv1988 but not with MBP (Fig. 2c). Further
confirmation was obtained by mutating the Adomet (SAM
binding) domain of Rv1988 and performing the in vitro
methyltransferase assay. In this assay, Rv1988Adomet mutant
was not able to methylate H3 (Fig. 2c, right panel). To identify the
residues within histone H3 that get methylated by Rv1988,
histone H3 incubated with Rv1988 was analysed by tandem
MS/MS, which indicated that arginine at the 42nd position of
histone H3 (H3R42) was methylated (Fig. 2d). To ascertain this,
arginine at H3R42 was changed to alanine by site-directed
mutagenesis followed by in vitro histone methyltransferase
assay using cold SAM, followed by western blotting and
probing with dimethyl arginine antibody. As a control, we also
mutated arginine at H3R2, H3R17 (known in literature to be
dimethylated19) and H3R83 (randomly selected) to alanine.
H3R42A showed negligible levels of arginine methylation as
compared with H3, H3R2, H3R17 and H3R83A suggesting that
H3R42 was the primary target of Rv1988 (Fig. 2e). As seen for
other histone arginine methyltransferases20,21, Rv1988 also
seemed to have a minor secondary target because of which
residual methylation was seen for the H3R42A mutant. This was
reconfirmed by performing this assay with tritiated SAM and
radiography (Supplementary Fig. 2). To examine whether other
histones were also methylated by Rv1988, histones were isolated
from HEK293 cells, incubated with cold SAM and Rv1988, and
probed with dimethyl arginine antibody. As a control, histones
were also incubated with Rv1988Adomet mutant in the in vitro
methyltransferase assay. Arginine methylation was detected only
for histone H3 (Fig. 2f).
Rv1988 is a secretory protein. For Rv1988 to function as a
histone methyltransferase in the host cell upon infection, the
mycobacterial cell would need to secrete it. We first tested Rv1988
secretion in vitro into the culture filtrate both for M. bovis BCG
and Rv1988-transformed M. smegmatis (does not have Rv1988
homologue) and grown in Sauton’s minimal media. Rv1988
(Mb2010 in M. bovis BCG) was detected predominantly in the
culture filtrate of both M. bovis BCG and Rv1988-transformed
M. smegmatis (Fig. 3a,b, upper panel). GroEL1 was used as
negative control for mycobacterial cell lysis (Fig. 3a,b, lower
panel). The identity of Rv1988 in culture filtrate of Rv1988-
6XHis-transformed M. smegmatis was confirmed by MS of
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Figure 2 | Rv1988 is a histone methyltransferase (HMTase). (a) Autoradiogram showing histone methylation activity of MBP-Rv1988 using tritiated SAM
as a methyl group donor and recombinant histone H3 as a substrate. MBP-LacZ and SUV39H1 proteins were used as negative and positive control,
respectively. Ponceau staining of histone H3 was used as a loading control. (b) In vitro HMTase assay result analysed by scintillation counting. The error
bars represent s.d. *Student’s t-test, *Po0.05. (c) Western blot for in vitro Rv1988 HMTase assay (as in a but using cold SAM) with dimethyl arginine
(upper panel) and histone H3 (lower panel) antibody. SAM-binding domain was mutated in MBP-Rv1988Adomet (Methods). (d) MS/MS spectra of histone
H3 peptide (amino acids 41–49) YRmePGTVALR (Arg42-methylated). In the spectra, the ‘b’ ions are labelled in blue and ‘y’ ions are labelled in red.
Evidence of Arg42 methylation is provided by b2 ion at 334.187m/z and y8 ion at 883.547m/z. (e) Western blot for in vitro HMTase assay with Rv1988
and recombinant histone H3 and its mutants H3R2A, H3R17A, H3R42A and H3R83A as substrates and cold SAM as methyl group donor, probed with the
indicated antibodies. (f) HMTase assay with histone proteins isolated from HEK293 cells, cold SAM and MBP-Rv1988 or MBP-Rv1988Adomet. The western
blot was probed with the indicated antibodies. M: Marker (19 kDa marker band is visible); 1: histonesþRv1988; 2: histonesþ Rv1988Adomet;
3: histones alone.
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Ni-NTA affinity-purified protein present in the culture filtrate
(Supplementary Fig. 3).
For their secretion, bacterial proteins are usually dependent
upon the Sec or Tat secretion pathways22. Bioinformatic analysis
of the Rv1988 protein sequence indicated the presence of
Tat-signal sequence (Z-R-R-x-F-F) within its N-terminus
(Supplementary Fig. 4). To confirm the secretory nature of
Rv1988 we mutated the twin arginine motif at positions R8 and
R9 to a twin alanine motif. M. smegmatis transformed with
Rv1988-6XHis or Rv1988R8A/R9A-6XHis was grown in Sauton’s
minimal media and the culture filtrate was tested for the presence
of Rv1988. Only Rv1988-6XHis protein was detected in culture
filtrate (lane 3, Fig. 3c). Rv1988R8A/R9A-6XHis was absent
from the culture filtrate (lane 4, Fig. 3c) confirming the
secretory nature of Rv1988. Transformation with Rv1988 or
Rv1988R8A/R9A did not affect the in vitro growth of M. smegmatis
in culture.
Rv1988 localizes to the chromatin upon infection. To confirm
the secretion of Rv1988 from the mycobacterial cell into the host
cell upon infection, mouse peritoneal macrophages were infected
with GFP::M. smegmatis or Rv1988-GFP::M. smegmatis strains
and the localization of GFP was examined by confocal micro-
scopy. As shown in Fig. 4a, the GFP fluorescence was limited to
within the boundary of the mycobacterial cell as visible in the
bright-field view (marked by a red line in the inset panels) for
GFP::M. smegmatis-infected peritoneal macrophages. However,
the GFP fluorescence was more diffused and spread throughout
the cell in Rv1988-GFP::M. smegmatis-infected peritoneal
macrophages (Fig. 4a). The same was true for Rv1988-GFP::
M. smegmatis-infected PMA-treated THP1 cells (THP macro-
phages, Supplementary Fig. 5).
Further confirmation of Rv1988 secretion into the host cell was
obtained by infecting larger numbers of THP1 macrophages
(B5 107 cells) with 6X His-Rv1988-transformed M. bovis BCG.
To detect Rv1988 in the host cell without lysing the mycobacterial
cell wall, cell lysate was prepared in an NTEN buffer containing
0.5% NP-40 (infected mycobacterial cells are known to remain
intact in this buffer23) and probed for the presence of Rv1988
using 6X His antibody. Rv1988 was indeed detected in this
infected THP1 cell lysate (Supplementary Fig. 6). GroEL1 protein,
a non-secretory mycobacterial protein, secreted was not detected
in this lysate confirming that M. bovis BCG bacilli were not lysed
(Supplementary Fig. 6, lower panel).
Rv1988 localized to the nucleus when Rv1988-GFP construct
was transiently transfected into HEK293 cells (Supplementary
Fig. 7, top panel). To confirm this in an in vivo infection
experiment, THP1 macrophages were infected with Rv1988-
6XHis::M. smegmatis. As a control, THP1 macrophages were
also infected with pVV16::M. smegmatis (vector control) or
Rv1988R8A/R9A-6XHis::M. smegmatis (non-secretory mutant of
Rv1988, see Fig. 3c). Forty-eight hours after infection, subcellular
fractionation of the infected THP1 macrophages24 was performed
taking care that intracellular mycobacterial cells did not lyse23.
Rv1988-6XHis was detected only in the chromatin fraction
(Fig. 4b, lane 7, Anti-His panel). The non-secretory mutant
Rv1988R8A/R9A was not detected in any of the fractions (lanes 2,
5 and 8). H3 was used as a control for the chromatin fraction,
GAPDH was used as a control for cytoplasmic fraction.
Mycobacterial non-secretory protein, GroEL1, was not detected
in any of the fractions confirming that M. smegmatis bacilli were
not lysed. This result clearly indicated that Rv1988 is not only
secreted into the host cell but has the capability to localize to the
chromatin of the host nucleus.
Using site-directed mutagenesis, we were also able to show that
the nuclear localization of Rv1988 was dependent on three
patches of basic amino acids present within the C-terminus of
Rv1988 (Supplementary Fig. 7).
Rv1988 mediates repression through H3-arginine methylation.
Modification of histones especially histone H3 have been very
well correlated with regulation of gene expression3. To examine
the role of Rv1988-mediated H3R42me2 in gene regulation,
luciferase reporter gene assay was performed in HEK293 cells
(Methods). If methylation of H3R42 by Rv1988 has any
regulatory effect, it should change luciferase expression. Upon
transfection of pG5luc with Rv1988-pBIND (Fig. 5a), significant
decrease of luciferase activity (B78%) was observed as
compared with luciferase activity when only pG5luc alone or
pG5lucþ pBIND vectors were transfected (Fig. 5b). Furthermore,
to test whether Gal4 assisted tethering of Rv1988 to the
Gal4-binding sites in the luciferase promoter leads to H3R42
dimethylation, we performed ChIP analysis using dimethyl
arginine antibody (R (me)2) for the luciferase promoter. As a
control we also examined the profile of known repressive histone
H3 modifications including H3K9me3 and H3K27me3. While we
did not observe any enrichment or depletion of H3K9me3 and
H3K27me3 for the luciferase promoter, significant enrichment
was observed for dimethyl arginine modification in cells co-
transfected with Rv1988-pBINDþ pG5luc as compared with
control pG5lucþ pBIND co-transfection (Fig. 5c). The observed
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Figure 3 | Rv1988 is secreted by mycobacteria. Rv1988 secretion in
M. bovis BCG (a) and Rv1988-transformed M. smegmatis (b). Western blot
showing cell lysate and culture filtrate of M. bovis BCG and Rv1988::M.
smegmatis was probed with Rv1988 and GroEL1 antibodies. Mb2010,
Rv1988 homologue in M. bovis BCG (a) or Rv1988 (b) was detected by
Rv1988 antibody (upper panel) in culture filtrate (lanes 1, 3) and cell lysate
(lanes 2, 4) of two independent cultures. (c) Mutation in the Tat-signal
sequence abolishes the secretory potential of Rv1988. Culture filtrate and
cell lysate for Rv1988-6XHis and Rv1988R8A/R9A-6XHis-transformed
M. smegmatis was probed for the presence of Rv1988. 1: cell lysate and
2: culture filtrate for Rv1988-6XHis::M. smegmatis; 3: cell lysate and
4: culture filtrate for Rv1988R8A/R9A-6XHis::M. smegmatis. GroEL1
(a non-secretory protein) antibody was used to examine cell lysis
(lower panel).
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Figure 4 | Rv1988 localizes to the host chromatin upon infection. (a) Mouse peritoneal macrophages infected either with GFP or Rv1988-GFP expressing
M. smegmatis analysed 48 h after infection by confocal microscopy. Scale bar, B10mm. Inset shows a ‘zoomed in’ view of the region marked by red box.
Scale bar, B1 and 2 mm (upper and lower panel, respectively). Some of the bacilli are outlined in red. Note rod-shaped structures stained by GFP in
GFP::M. smegmatis-infected peritoneal macrophages as against a diffused GFP signal in Rv1988-GFP::M. smegmatis-infected peritoneal macrophages.
(b) Rv1988 localizes to the host chromatin. Subcellular fractions (as indicated below the panels) of THP1 cells infected with Rv1988-6XHis::M. smegmatis
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Figure 5 | Rv1988 mediates transcriptional repression. (a) Line diagram describing luciferase reporter gene assay strategy in HEK293 cells. The 5 UAS
sites for GAL4 binding in pG5luc are shown as open rectangles. The filled shapes indicate fusion protein produced by pBIND-Rv1988 vector construct.
Raised arrow indicates transcription start site. (b) Rv1988 represses transcription. Luciferase activity from pG5luc measured 48 h after co-transfection of
various combinations of constructs as indicated. The values are represented as ratio w.r.t. luciferase activity of pG5luc vector alone and were normalized for
transfection efficiency w.r.t. GFP expression from a co-transfected GFP construct. (c) ChIP analysis for association of various histone modifications
(indicated below the x-axis) with the reporter luciferase gene promoter. Enrichment for each modification is represented as percentage input. The error bars
represent s.d. Student’s t-test, *Po0.05; ***Po0.0001. (d) Enrichment of H3-arginine dimethylation. ChIP performed on HEK293 cells transfected with
Rv1988 or vector alone constructs using histone H3 antibody and analysed for arginine dimethylation (upper panel) and histone H3 (lower panel).
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enrichment was indeed for arginine dimethylation in histone H3
as substantial increase in the level of histone H3 dimethylated at
arginine was observed in HEK293 cells transfected with Rv1988
as compared with vector alone (Fig. 5d).
H3R42me2-mediated gene repression by Rv1988 during infection.
Two sets of genes were chosen to examine the role of Rv1988
in H3R42me2-mediated gene regulation during infection of
macrophages by mycobacteria. First, we identified a few genomic
loci in the human genome to which Rv1988 bind (Supplementary
Fig. 8). Of these, the sequence for region B and C (Supplementary
Table 1) were not repetitive in nature and present, respectively,
within the intron of CDC42BPB and ENSG00000250584, a novel
lincRNA. Two immunologically important genes, TRAF3 and
TNFAIP2, were present in the same genomic locus as region B.
We examined these 4 genes for their expression in GFP-
Rv1988::M. smegmatis-infected THP1 cells. Second, we observed
decrease in reactive oxygen species (ROS) activity of GFP-
Rv1988::M. smegmatis-infected THP1 cells (Supplementary
Fig. 9). Therefore, we decided to examine the gene expression
levels of a few genes known to be involved in ROS production
including NOX1, NOX4 (NADPH oxidases, involved in produc-
tion of Oxygen radicals25), NOXA1 (NOX-activating protein26)
and NOS2 (nitric oxide synthase, involved in the formation of free
radicals27).
We first examined gene expression of the above-mentioned
genes in THP1 macrophages infected with GFP::M. smegmatis or
Rv1988-GFP::M. smegmatis by qRT-PCR. As shown in Fig. 6a,
except for CDC42BPB, all other genes including the novel
lincRNA, ENSG00000250584, were repressed in Rv1988-GFP::M.
smegmatis-infected THP1 cells, confirming the repressive
influence of Rv1988 on gene expression that we had earlier
observed in the in vitro experiments (Fig. 5b).
To find whether the repression observed for these genes was
associated with the binding of Rv1988 to their promoters, THP1
macrophages either infected with pVV16::M. smegmatis or
Rv1988-6XHis::M. smegmatis were subjected to ChIP using a
ChIP grade 6XHis antibody (as Rv1988 antibody was found to be
good only for western blot analysis). Significant enrichment of
Rv1988 was observed at the promoters of NOX1, NOX4, NOS2
and the lincRNA, ENSG00000250584 in THP1 macrophages
infected with Rv1988-GFP::M. smegmatis (Fig. 6b). This indicated
that Rv1988 was indeed bound to the promoters of these genes.
For analysing the histone H3 modifications, ChIP was also done
with antibodies to dimethyl arginine, H3K4me3, H3K9me3 and
H3K27me3 on THP1 macrophages infected with GFP::M.
smegmatis and Rv1988-GFP::M. smegmatis, for the above-
mentioned gene promoters, as well as for the regions B and
C present within CDC42BPB and the novel lincRNA,
ENSG00000250584 that we had identified to be bound to
Rv1988 in our screen (Supplementary Table 1). Except for
NOXA1, promoters of all other genes that showed decrease
in their expression in Rv1988-GFP::M. smegmatis-infected
THP1 macrophages showed significantly more association with
dimethylated arginine (Fig. 6c). CDC42BPB expression was
unaffected upon Rv1988-GFP::M. smegmatis infection and its
promoter association was also not associated with dimethyl
arginine (Fig. 6c). No change was observed for the association of
H3K9me3 and H3K27me3, the known repressive chromatin
marks, with the promoters of these gene upon infection with
Rv1988-GFP::M. smegmatis (Fig. 6d,e). In fact, NOS2 showed
decrease in association with the repressive H3K27me3 mark even
though its expression level had decreased (Fig. 6e). Only a few of
the gene promoters (NOXA1, NOX4 and the ENSG00000250584
lincRNA) showed decreased association with H3K4me3, the
active chromatin-associated histone mark, in Rv1988-GFP::M.
smegmatis-infected THP1 cells (Fig. 6f). Both the Rv1988-bound
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Figure 6 | Infection with Rv1988::M. smegmatis represses specific host genes. (a) Expression levels of the indicated genes measured by real-time
qRT-PCR in THP1 macrophages infected with M. smegmatis expressing Rv1988 (black bars, Rv1988) or GFP::M. smegmatis (white bars, GFP). Levels were
normalized against GAPDH. ncRNA: lincRNA ENSG00000250584. (b–f) Epigenetic modifications associated with the gene promoters. (b) Rv1988 binding;
(c) dimethyl arginine; (d) H3K9me3; (e) H3K27me3; (f) H3K4me3. Region (b,c) were present within the intron of CDC42BPB and lincRNA
ENSG00000250584, respectively. The error bars represent s.d. Student’s t-test, *Po0.05.
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regions B and C present within the introns of CDC42BPB
and ENSG00000250584 lincRNA also showed significantly
higher association with dimethyl arginine in Rv1988-GFP::M.
smegmatis-infected THP1 macrophages (Fig. 6c) but not with the
other histone modifications tested (Fig. 6d–f). Control IgG ChIP
is shown in Supplementary Fig. 10. To confirm that the Rv1988
was affecting the levels of histone H3 dimethyl arginine, IP of H3
followed by western blotting with dimethyl arginine antibody
was carried out on THP1 macrophages infected with Rv1988-
6XHis::M. smegmatis, pVV16::M. smegmatis (vector control) or
Rv1988R8A/R9A-6XHis::M. smegmatis. Significant increase in the
level of H3-arginine methylation was detected only in THP1
macrophages infected with Rv1988-6xHis::M. smegmatis
(Supplementary Fig. 11).
To examine whether Rv1988 was also responsible for
H3-arginine methylation-mediated repression of the above-
mentioned genes during M. tuberculosis infection of THP1
macrophages, Rv1988 was deleted from the M. tuberculosis
H37Rv strain by recombineering28 (Fig. 7a). Replacement of
Rv1988 region from the endogenous locus with the Hygromycin
cassette was confirmed by PCR using various combinations of
primers (Fig. 7b). The absence of Rv1988 protein from the
mutant M. tuberculosis H37Rv (DRv1988) was confirmed by
western blotting using Rv1988 antibody (Fig. 7c). Both the
strains,M. tuberculosis H37Rv and mutantM. tuberculosis H37Rv
(DRv1988), showed similar in vitro growth in culture.
The gene expression level of the chosen genes (as in Fig. 6a)
was quantified by qRT-PCR for THP1 macrophages infected with
either M. tuberculosis H37Rv or mutant M. tuberculosis H37Rv
(DRv1988) strains. Except for NOXA1, all genes that were
repressed in THP1 macrophages infected with Rv1988-GFP::M.
smegmatis showed higher expression in mutant M. tuberculosis
H37Rv (DRv1988) strain as compared with the wild-type
M. tuberculosis H37Rv strain (Fig. 7d). This corroborated our
earlier findings (Figs 5b and 6a) that Rv1988 has a repressive
influence on gene expression.
To prove that Rv1988-mediated repression was owing to
H3-arginine methylation, ChIP was performed on the chromatin
from THP1 macrophages infected with either wild-type or
DRv1988 strains of M. tuberculosis H37Rv first with H3 antibody.
A second round of ChIP using the dimethyl arginine antibody
was performed on the bound fraction from the H3 ChIP to obtain
chromatin-associated DNA only with histone H3 having
methylated arginine. As seen with Rv1988-GFP::M. smegmatis,
the promoters of all genes except NOXA1 and CDC42BPB showed
significantly higher association with H3 having dimethylated
arginine in THP1 macrophages infected with M. tuberculosis
H37Rv as compared with infection with DRv1988 mutant of
M. tuberculosis H37Rv (Fig. 7e). As a control, ChIP was also
performed with IgG (Supplementary Fig. 12).
To further establish that during mycobacterial infection, the
Rv1988-mediated methylation of arginine residues in H3 was at
R42, polyclonal antibodies specific to H3R42me2 were raised and
purified (Supplementary Fig. 13). Western blot analysis with this
antibody showed that the level of H3R42me2 was significantly
higher in THP1 macrophages infected with M. tuberculosis
H37Rv (lane 2, Fig. 7f) as compared with DRv1988 mutant of
M. tuberculosis H37Rv (Fig. 7f, lane 1). In the same experiment,
no significant difference was observed in the level of H3R2me2.
To examine H3R42me2 levels for individual genetic loci, ChIP
analysis was also performed using H3R42me2 antibody for the
promoters of the selected genes (as in Fig. 7e). Except for NOXA1
and CDC42BPB, all the gene promoters showed significant
decrease in the levels of H3R42me2 during infection with
DRv1988 mutant of M. tuberculosis (Fig. 7g) mirroring our ChIP
results with H3þ dimethyl arginine antibody (Fig. 7e). This
would indicate that the repression of these genes during
M. tuberculosis was being mediated through dimethylation of
H3R42.
Rv1988 is a mycobacterial virulence factor. The ability to
survive within the host macrophages is an important character-
istic that differentiates the pathogenic M. tuberculosis
from the non-pathogenic M. smegmatis29. The survivability of
M. smegmatis transformed with candidate genes in macrophages
has been used as an important tool to judge the importance of a
gene in pathogenicity of M. tuberculosis30. To investigate the
importance of Rv1988 during infection, we first performed
infection experiments with Rv1988-transformed M. smegmatis.
Mouse peritoneal macrophages in culture were infected with
either Rv1988-6XHis::M. smegmatis, Rv1988R8A/R9A-6XHis::M.
smegmatis or pVV16::M. smegmatis strains and the number of
surviving intracellular bacilli were estimated at 0, 12, 24 and 48 h
after infection. As shown in Fig. 8a, Rv1988 provided a significant
survival advantage to M. smegmatis upon infection into
peritoneal macrophages at all the time points for which we
examined the numbers of surviving intracellular bacteria. The
survival of theM. smegmatis expressing the non-secretory mutant
of Rv1988, Rv1988R8A/R9A, was significantly lower than Rv1988-
6XHis::M. smegmatis and similar to pVV16::M. smegmatis
(Fig. 8a).
To test whether this was also true during animal infection
experiments, BALB/c mice were injected intravenously with
Rv1988-6XHis::M. smegmatis or pVV16::M. smegmatis (control)
and the bacterial load was analysed in liver, lung and spleen of the
infected mice. Seven days after infection the bacterial load was
found to be significantly more (Po0.0001) for M. smegmatis that
was expressing Rv1988 for all the three tissues analysed (Fig. 8b).
The bacterial load was maximum for liver followed by spleen and
was least in the lungs. This was even true 20 days after infection
(Fig. 8c) though the total bacterial load had decreased in each
tissue.
While performing the animal infection experiment we noticed
that there was significant body weight loss amongst mice infected
with Rv1988-6XHis::M. smegmatis. To test the significance of this
observation we monitored the body weights of uninfected and
Rv1988-6XHis::M. smegmatis- and pVV16::M. smegmatis-
infected mice. As expected the uninfected mice showed increase
in body weight over 20 days (Fig. 8d, n¼ 5). While both Rv1988-
6XHis::M. smegmatis- and pVV16::M. smegmatis-infected mice
showed decrease in body weight initially (on day 4 after
infection), decrease in body weight of Rv1988-6XHis::M.
smegmatis-infected mice was significantly more as compared
with pVV16::M. smegmatis-infected mice (Po0.0001, n¼ 16 for
both groups). Subsequently (7th day onwards), pVV16::M.
smegmatis-infected mice showed signs of regaining body weight
and by 20 days most of the animals in this group had more weight
than on the day of the infection. However, the Rv1988-6XHis::M.
smegmatis-infected mice continued to show loss of body weight
throughout and on day 20 post infection the mice in this group
had on an average 35% lower weight than the pVV16::M.
smegmatis-infected mice (Fig. 8d). Gross examination of the
various organs indicated considerable enlargement of spleen in
mice infected with Rv1988-6XHis::M. smegmatis (Fig. 8e).
Rv1988 is present only in the pathogenic mycobacterial species
like M. bovis and M. tuberculosis. To assess the importance of
Rv1988 in pathogenicity, THP1 macrophages were infected with
either M. tuberculosis H37Rv or M. tuberculosis H37Rv-DRv1988
(DRv1988 mutant) and the numbers of surviving intracellular
bacteria were calculated at 0, 12, 24 and 48 h after infection. As
can be seen from the Fig. 8f, deletion of Rv1988 significantly
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reduced the number of surviving intracellular mycobacteria as
early as 12 h post infection. This indicated that Rv1988 was
indeed one of the virulence factor for M. tuberculosis.
Discussion
The outcome of an infection by a pathogenic intracellular bacteria
would depend on the quantum of response that the host cell
mounts against the bacteria on one hand, and the capability of the
pathogen to modulate the host cellular machinery on the other.
Several studies have shown examples of how the pathogenic
mycobacteria uses its repertoire of proteins to modulate the host
cell. Most of these proteins work at the level of cell surface and a
few have been shown to interact with the host cell machinery in
the cytoplasm31,32.
We show here that mycobacteria upon infection secretes the
protein Rv1988 in to the host cell, which then localizes to the
chromatin and modulates the expression of genes important for
mounting immune response against infectious bacteria through
histone H3 methylation. Both in vitro histone H3 methylation
assay and in vivo ChIP analysis on infected host macrophages
(sequential double ChIP with H3 and dimethyl arginine
antibodies, as well as a ChIP with H3R42me2 antibody)
confirmed that Rv1988 dimethylates histone H3 at R42. The
interaction of Rv1988 with the host epigenetic circuitry through
the non-tail core histone H3-arginine methylation (H3R42) is
noteworthy because H3R42 is present at the critically important
entry/exit point of DNA in the nucleosome that has the potential
to change nucleosomal dynamics and affect transcription33,34.
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Figure 7 | Rv1988 is required for H3 methylation during M. tuberculosis infection. (a) Generation of M. tuberculosis Rv1988 gene replacement mutant.
Schematic representation of the strategy used for the generation of Rv1988 gene replacement mutant. (b) PCR amplifications were performed using specific
primers (depicted with red arrows in a) as indicated below the agarose gel, using genomic DNA of M. tuberculosis H37Rv and DRv1988 mutant. Left panel
shows the PCR amplification with F1-R2 pair which gives a product of 2.2 kb for H37Rv and 2.9 kb for DRv1988. Right panel shows PCR amplification with
F1-R1 and F2-R2, which do not give any product with Rv genomic but yield a 2.2 kb product DRv1988 mutant. Mr: Marker, Rv: M. tuberculosis H37Rv, D1988:
DRv1988 mutant. (c) Absence of Rv1988 protein from DRv1988 mutant. Western blot performed with cell lysate of M. tuberculosis H37Rv (lane 1) and
DRv1988 mutant (lane 2) was probed with Rv1988 and GroEL1 (control) antibodies. (d) Rv1988 represses specific host genes. Expression levels of
the indicated genes measured by real-time qRT-PCR in THP1 macrophages infected with M. tuberculosis H37Rv (white bars, WT) or M. tuberculosis
H37Rv-DRv1988 mutant (black bars, DRv1988). Levels were normalized against GAPDH. ncRNA: lincRNA ENSG00000250584. (e) Histone H3-arginine
methylation by Rv1988. Double ChIP was performed, using histone H3 and dimethyl arginine antibodies (Methods), on THP1 macrophages infected with
M. tuberculosis H37Rv and DRv1988 mutant. Association of histone H3, dimethylated for arginine residue, with the promoters of the indicated genes was
analysed by quantitative real-time PCR. (f) Western blot to compare the H3R42me2 levels between THP1 macrophages infected withM. tuberculosis H37Rv
(lane 1) or DRv1988 mutant (lane 2). As a control the blot was also probed with H3R2me2 and H3 antibodies. (g) Histone H3R42 dimethylation by Rv1988.
ChIP was performed using histone H3R42me2 antibody on THP1 macrophages infected with M. tuberculosis H37Rv and DRv1988 mutant. Association of
histone H3, dimethylated at R42, with the promoters of the indicated genes was analysed by quantitative real-time PCR. The error bars represent s.d.
Student’s t-test, *Po0.05, **Po0.01.
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The more important point to note here is the preference of
Rv1988 for a non-tail core histone H3-arginine H3R42.
Mammalian histone methyltransferase normally target the
lysines or arginines in the N-terminal tail of H3 including
H3K4, H3K9, H3K27, H3R2, H3R8, H317 or H3R26 (refs 3,35).
That bacteria use proteins to methylate histones at non-canonical
sites was also borne out by the study of Rolando et al14 who
showed that RomA protein of Legionella methylates histone H3 at
lysine 14, a modification not shown to be methylated in
mammalian cells. Recent work from our laboratory has shown
that mycobacteria use Rv2966c to methylate host DNA non-
canonically predominantly at non-CpG cytosines16. The reason
as to why pathogenic mycobacteria uses this non-canonical
regulatory machinery can only be answered once we fully
understand the mechanism by which methylation of H3R42
regulates transcription.
A recent study showed by in vitro synthetic chromatin
experiments that H3R42me2, in presence of p53 and p300, acts
to positively influence transcription34. On the other hand, in
yeast, where a lysine is present instead of arginine at 42nd
position, H3K42me2 causes gene repression33. Importantly,
transcription repression persisted even when this lysine was
replaced with arginine33. Both in in vitro reporter gene assay and
in vivo infection experiments, we observed, repression owing to
histone H3-arginine dimethylation by Rv1988. The difference in
the results could be related to the use of synthetic chromatin
in vitro transcription assay34 versus the in vitro reporter
gene assay and in vivo infection studies (this study). It is
also possible that the difference was owing to symmetric
versus asymmetric arginine dimethylation that is known to
have opposite effects on transcription36,37. Structure-based
characterization of methyltransferase activity of Rv1988 would
be able to shed light on this difference.
Decrease in ROS activity in THP1 macrophages infected by
Rv1988::M. smegmatis strain indicated that the expression of
Rv1988 in the infecting M. smegmatis had triggered the
attenuation of the host machinery involved in ROS production
considered to be the first line of defence against infectious
agents38. The decrease in ROS activity correlated with Rv1988-
binding and H3-arginine methylation-associated decrease in the
expression of NADPH oxidase (NOX1 and NOX4) and nitric
oxide synthase (NOS2) genes. Components of the free-radical-
generating machinery were not the only factors that were targeted
by Rv1988. TRAF3, the TNF receptor-associated factor, plays an
important role in both B-cell and T-cell dependent immune
response39. The histone H3-arginine methylation-dependent
transcriptional repression of TRAF3 in Rv1988::M. smegmatis-
infected THP1 cells indicated that mycobacteria uses Rv1988 to
target specific genes important in mounting an immune response.
This was also supported by our finding that the association of
these promoters with H3R42me2 was significantly higher during
infection of THP1 macrophages with M. tuberculosis H37Rv as
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at 1:10 MOI. The error bars represent s.d. Student’s t-test, *Po0.05, **Po0.001, ***Po0.0001.
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compared with the M. tuberculosis-DRv1988 strain. The
mechanisms by which these genes are targeted and the reasons
why these genes are targeted would be the next step in
understanding how Rv1988 modulates gene expression through
its interaction with the host epigenetic circuitry.
NOXA1, a protein involved in ROS production and TNF2AIP,
a protein regulated by TNFa showing repression that did not
correlate with H3-arginine methylation could be indicative of
repression at this loci as a secondary effect of Rv1988 action. The
identification of the complete subset of genes targeted by Rv1988
is an important question that needs to be addressed. However, the
aim of our study was to show that a mycobacterial protein could
modulate host genome by directly interacting with its chromatin,
that Rv1988 is able to methylate histone H3 at a non-canonical
Arginine (H3R42) and that this modification is able to repress
a subset of immunologically important genes confirms our
contention.
Apart from gene promoters, we have also shown H3-arginine
methylation at intragenic sites that were identified as Rv1988-
bound sites (Fig. 6c). This could suggest targeting of regulatory
elements in the host genome by Rv1988. Our hypothesis was
strengthened by the fact that while Rv1988-bound ‘region B’
within the CDC42BPB intron showed increased association with
dimethyl arginine in THP1 cells infected with Rv1988::M.
smegmatis, the expression of CDC42BPB itself was not altered.
On the other hand, the association with H3 dimethyl arginine and
repression was observed for TNFAIP2 and TRAF3, genes that are
present almost 300–500 kb away from region B, indicating that
the region within CDC42BPB probably was a regulatory element
for TRAF3 and TNFAIP2. Moreover, the finding that the
expression of lincRNA ENSG00000250584 was also altered fits
well with the known regulatory role of lincRNAs40.
Several M. tuberculosis proteins have been shown to be
important for its virulence as judged by decrease in survivability
of M. tuberculosis strains deleted for the specific gene or increase
in survivability of the non-pathogenic mycobacterial species,
M. smegmatis, expressing these genes, within the host macro-
phage cell29,30. Most of these proteins are located on the
mycobacterial cell surface, while some have been shown to be
secreted in to the host cytoplasm31,32. The secretion of Rv1988
into the host was beneficial for the mycobacterium as the survival
of M. smegmatis, which is known to be cleared very quickly from
the macrophage both in vitro and in animal infection studies, was
significantly better when it was expressing Rv1988. The survival
ability of Rv1988::M. smegmatis in the various tissues during
animal infection studies was also markedly improved and was
reflected in the diminished health of the infected animals as even
20 days after infection they were not able to regain their body
weight. In addition, M. tuberculosis H37Rv strain deleted for
Rv1988 was found to have significantly less survival ability after
infection inside the macrophages.
As epigenetic modifications play a crucial role in maintaining
the transcription profile of a mammalian cell, epigenetic effectors
including histone modifiers are important for the well-being of a
cell. Several examples are known especially from the field of
cancer where changes in the epigenetic and transcriptional profile
of a cell are correlated with nuclear reprogramming and aberrant
cell function41. The reduced survivability of M. tuberculosis
H37Rv-DRv1988 mutant, increased survival potential of
Rv1988::M. smegmatis and negative impact of Rv1988 on the
health of the infected animal suggests that its action as a histone
methyltransferase had affected the epigenetic landscape of the
infected cells and the animal was finding it difficult to overcome
this challenge leading to decreased fitness.
In summary, ours is the first report of a mycobacterial protein
that acts directly at the level of host chromatin, methylates
histone H3 at a non-canonical arginine residue (H3R42) present
within its core-structured region, represses immunologically
important genes and adversely affects the health of infected
mice. Methylation of a crucial arginine, placed at the entry/exit
point of DNA in the nucleosome and not within the known
epigenetically important N-terminal tail of histone H3 indicates
use of a novel mechanism by the pathogenic mycobacterium to
subdue the host cell. This perhaps also could be one of the
reasons why the host cell is not able to respond effectively when
infected by a pathogenic mycobacterium species. Identification of
Rv1988 as an important mycobacterial virulence factor, which
uses an epigenetic mechanism to control transcription through a
non-canonical mechanism, augurs well for it to be a potential
target for therapy against mycobacterial infections.
Methods
Purification of H3-interacting proteins from M. bovis BCG. To identify M. bovis
BCG proteins that interact with histone H3, E. coli-purified 6X His-tagged histone
H3 was allowed to bind to pre-equilibrated Ni-NTA beads in buffer containing
50mM Tris-HCl, pH 8, 100mM NaCl, 1% NP-40 and 10% Glycerol, followed by
incubation with pre-cleared M. bovis BCG lysate for 4 h. Ni-NTA beads alone were
also incubated with M. bovis BCG lysate as control. Beads were washed five times
with the same buffer but containing 25mM Imidazole. Bound proteins were
resolved on a 12% SDS–polyacrylamide gel electrophoresis. The prominent bands
present only in H3 incubated fraction were cut and analysed by MS.
Pull-down and IP assays. Rv1988 having N-terminal SFB-tag was cloned into
pCDNA3.1 and transfected into HEK293 cells (a kind gift from Dr Gayatri
Ramakrishna, who obtained it from the Cell Culture Stock Centre at National
Centre for Cell Science (NCCS), Pune). Forty-eight hours after transfection,
cells were lysed in a buffer containing 20mM Tris-HCl, pH 8.0, 100mM NaCl,
1mM EDTA, 0.5% Nonidet P-40, 50mM b-glycerophosphate, 10mM NaF and
protease inhibitors. Lysate was incubated with pre-equilibrated Streptavidin beads
for 3 h, the beads were washed five times with the same buffer, loaded on a
SDS–polyacrylamide gel electrophoresis after resuspending them in 6 -SDS
sample loading buffer and western blotted. The blot was probed with H3 antibody
(Abcam). For reverse IP, same procedure was followed except IP was done with H3
and IgG (Invitrogen) antibodies and probed with anti-FLAG (Sigma) antibody.
Site-directed mutagenesis. Site-directed mutagenesis was performed to derive
the following mutants:
For Rv1988:
(i) Adomet mutant—was generated by mutating Asp38 (GAC) to Gly38 (GGC)
and Gly40(GGC), Gly42(GGC) and Gly44(GGG) to Ala(GCG) using
PCR-based site-directed mutagenesis.
(ii) TAT mutant—was generated by mutating Arg8(CGA) and Arg9(CGG) to
Ala8(GCA) and Ala9(GCG).
For histone H3:
(i) Arginine at 2, 17, 42 and 83 to Alanine.
Histone methyltransferase assay. In vitro histone methyltransferase assay was
performed by incubating 2 mg of recombinant Rv1988 protein with 1–2 mg of
recombinant histone H3 or its mutants and 0.2mM cold SAM (NEB) or 2 mCi
3H-SAM (American Radiolabelled Chemicals) in buffer containing 50mM
Tris-HCl (pH 8.0), 10% glycerol, 5mM MgCl2, 20mM KCl and 1mM PMSF at
30 C overnight. The reaction mixture was resolved on a SDS–polyacrylamide
gel electrophoresis, electroblotted on polyvinylidene fluoride membrane (GE
Healthcare) sprayed with Enhancer Spray (Perkin Elmer) and kept for exposure for
7 days at  80 C. For scintillation counts, reaction was stopped by adding 10%
TCA and mixture was spotted on GF/C filters (Sigma) using vacuum manifold
and washed thrice with 10% TCA and twice with absolute Ethanol. Filters were
dried and put in vials containing scintillation fluid and counts were taken in a
scintillation counter (Perkin Elmer).
Mass spectrometry. After the methyltransferase assay, samples were resolved on
a SDS–polyacrylamide gel electrophoresis, bands were cut and send for MS (was
performed either at CDFD’s in-house mass spectrometer (Bruker) or Taplin Mass
spectrometric Facility, Harvard, USA) or MS/MS (Taplin Mass spectrometric
Facility).
Transfection and localization of GFP-tagged proteins. Rv1988 cloned into
pEGFP-C3 or pEGFP-C3 alone (control) were transfected in HEK293 cells using
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Lipofectamine 2000 (Invitrogen). Forty-eight hours after transfection, the cells
were fixed with 3.7% formaldehyde (Sigma) for 10min, permeabilized using
0.1% triton-X-100 and mounted by using DAPI containing Vectashield mounting
media (Invitrogen). Cells were visualized under a confocal microscope (Zeiss).
Preparation of mycobacterium culture filtrate. The culture filtrate preparation
for M. bovis BCG and M. smegmatis was done as described below. To obtain
Rv1988-transformed M. smegmatis, electrocompetent M. smegmatis were trans-
formed with 1 mg DNA construct of pVV16-Rv1988 as per standardized protocol42.
Colonies obtained after 3 days were inoculated in 5ml Modified Sauton’s media
with kanamycin and hygromycin (Invitrogen). Secondary cultures were derived
using 1% primary inoculum in Modified Sauton’s media. Cultures were collected at
0.8 (OD600) by centrifugation at 8,000 r.p.m. for 30min. The supernatant was
passed through 0.45 mm filters to remove cell contamination remains and
concentrated 100 using 10 kDa Centricon (Millipore). Cell lysate was prepared
by sonication. Glass beads were added to the lysate during the sonication for better
yields.
Rv1988 antibody was raised against the E. coli-purified Rv1988 protein in mice.
The specificity of the antibody was confirmed by peptide competition assay
(Supplementary Fig. 14).
Generation of M. tuberculosis Rv1988 gene replacement mutant. The 50
homology sequence ( 880 to 100 bp) and the 30 homology sequence (438 to
þ 851 bp) of Rv1988 were amplified from the H37Rv genomic DNA with the help
of specific primers and phusion DNA polymerase. The primers for the flanks were
designed such that PflMI digestion would results in ends that are compitable for
cloning with hygr cassette (amplified using specific primers) and oriEþ cosl
fragments generated from pYUB1474 construct (a kind gift from Drs William
Jacobs and Apoorva Bhatt43). In addition to the PflMI site, we have inserted a
SnaBI site in the 50 flank forward and 30 flank reverse primers. Amplicons of 50
homology sequence, 30 homology sequence and hygr cassette were digested with
PflMI and ligated with oriEþ cosl fragment from pYUB1474 to generate AES.
AES was digested with SnaBI to generate linear allelic exchange substrate for the
recombineering. M. tuberculosis H37Rv was electroporated with pNit-ET (a kind
gift from Dr Eric Rubin44) to generate recombineering proficient H37Rv::pNit-ET
strain. H37Rv::pNit-ET cultures were grown till A600 of 0.4 and the expression of
recombineering genes were induced by the addition of 0.5 mM isovaleronitrile and
the cultures were allowed to grow till A600 of 1.0. Electrocompetent cells were
prepared as described previously28 and the cells were electroporated with 100 ng of
linear allelic exchange substrates and colonies were selected on 7H11 agar plates
containing 100mgml 1 hygromycin. Few of potential mutants obtained were
cultured and genomic DNA was isolated. To confirm genuine gene replacement
mutant, the potential mutants were screened using specific primers (Fig. 7a,b). The
M. tuberculosis work was performed in the P3 facility of National Institute of
Immunology, Delhi, India as per approved IBSC guidelines.
Infection of THP1 cells and peritoneal macrophages. In all, 0.3 106 THP1 cells
(obtained from ATCC) were seeded per chamber and treated for 12 h with 10 ng of
PMA. After 24 h of recovery in PMA-free RPMI medium, infection was done with
different strains of M. smegmatis or M. bovis BCG in antibiotic-free media at an
MOI of 30:1 for 6 h. Cells were washed twice with PBS and cultured further in
media containing antibiotics. Cells were fixed or assayed at different time points as
indicated. Peritoneal exudates cells were collected from BALB/c mice as per the
approved IEAC guidelines (PCD/CDFD/15) and seeded in 12-well culture dishes
or chamber slide at a density of 0.5 106 and 0.3 106, respectively. Infections
were done as described above for THP1 cells. For infection with M. tuberculosis,
H37Rv and DRv1988 strain were grown up to an OD of 0.8. Bacterial cells were
washed twice with PBS and were finally re-suspended in 10ml of RPMI medium.
Smooth bacterial suspension was made by passaging the cells 10 times through
271/2 G needle syringe. The OD was re-checked and infection was done at 1:10
MOI. The infection was allowed for 4 h and was followed by addition of media
containing gentamycin for 2 h to remove extracellular bacteria. Each time point for
infection with both strains was represented by three wells. At each time point cells
were lysed in 1ml 0.1% triton-X-100 and three dilutions of each were plated on
plain 7H11 plates. The CFUs hence obtained after incubation at 37 C were
counted.
Mice. All animal experimentation was in accordance with the guidelines of
CPCSEA Government of India at VIMTA Labs Limited, Hyderabad. The protocol
was approved by the Institutional Animal Ethics Committee (IAEC) of the Vimta
Labs (IAEC protocol approval number: PCD/OS/17 dated 14 June 2014). BALB/c
mice, initially procured from Indian Institute of Science, Bangalore, India and bred
in-house were used in these experiments.
Mouse infection. Four-to-six-week-old male BALB/c mice were injected intra-
venously (tail vein) with different strains of M. smegmatis (using B2 107 bac-
teria) as per the approved IEAC guidelines (PCD/CDFD/17). Seven days or
20 days post infection, mice were killed. To examine the bacterial load in lung,
liver and spleen, the organs were homogenized in 1ml PBS. Body weight of the
individual mice was also taken at different times after infection as indicated.
CFU estimation. For peritoneal macrophages and THP1 cells, cells were washed
twice with PBS and incubated in PBS containing 0.2% triton-X-100 for 10min for
lysis. After lysis serial dilutions were made and 100ml from each dilution was plated
on 7H10 agar containing hygromycin and kanamycin. After 3 days colonies were
counted, the exact CFU count was obtained by applying the dilution factor.
For CFU calculation in mice infection experiments, homogenized tissues were
re-suspended in 1ml PBS, followed by serial dilution and 100 ml from each dilution
was plated on 7H10 agar containing hygromycin and kanamycin.
ROS assay. PMA-treated THP1 cells or peritoneal macrophages were infected
with different M. smegmatis strains as described earlier. For ROS estimation
equal numbers of infected THP1 cells were collected at different time points
washed twice with PBS and re-suspended again in 100ml PBS. 1 mM H2DCFDA
(Sigma) was added to the cell suspension and incubated for 40min in dark at
37 C. Cells were again washed and re-suspended in PBS and DCF fluorescence
was taken at 488/510 nm excitation and emission, respectively, in 96-well plate45.
Luciferase reporter gene assay. Rv1988 was cloned into pBind vector (Promega)
containing Gal4 domain. pG5Luc vector was used as a reporter Luciferase
construct that contains UAS sites (Gal4 binding) upstream of the Luciferase
reporter gene. pEGFP-C3vector was used as a control for transfection efficiency.
HEK293 cells were transfected using lipofectamine 2000 (Invitrogen), with either
of the following three combinations (i) Rv1988-pBindþ pG5Lucþ pEGFP-C3;
(ii) pBINDþ pG5Lucþ pEGFP-C3; (iii) pG5Lucþ pEGFP-C3. After 48 h of
transfection whole-cell lysate was prepared and Luciferase activity was measured
using Luciferase assay system as per the manufacturer’s protocol (Promega).
The same lysate was also probed with GFP antibody (Sigma) to monitor the
transfection efficiency. Densitometry of the blot was done and values for GFP
were used to normalize the respective luciferase values.
Expression analysis by real-time PCR. THP1 cells were infected with various
strains ofM. smegmatis and collected 48 h post infection followed by RNA isolation
using TRI reagent (Sigma). In all, 1 mg DNase-treated RNA was used for cDNA
preparation using Superscript III (Invitrogen). Expression analysis by real-time
RT-PCR using SYBER Green Master Mix (Thermo Scientific) in ABI Prism SDS
7500 system. Ct were normalized with Ct of GAPDH which was used as internal
control. Each experiment was done in duplicates and repeated with three biological
replicates. The primers used were as following:
NOXA1F 50-ACGTCCTGTGTGAAGTGGACC-30
NOXA1R 50-ATGGACACAGCATCATTAGGGC-30
NOX1F 50-AATCCTTGGGTTTTGCAGCC-30
NOX1R 50-GTCGTGTTTCGGGACTGGAT-30
NOS2F 50-AAGCAGCAGAATGAGTCCCC-30
NOS2R 50-CCTGGGTCCTCTGGTCAAAC-30
TNFAIP2F 50-TACCCTGACTTCAGCAAAGGC-30
TNFAIP2R 50-CACAGGAAAAGCTAACCAACCT-30
TRAF3F 50-ATGATCGCGCTGCAGGTTT-30
TRAF3R 50-TGTCTGCTTCCTCCCAGTTC-30
CDCBPBF 50-GACGCACACTGTCAGAGGAA-30
CDCBPBR 50-GCTTCTGTATGAACTTCCAGCTCT-30
ncRNAF 50-AGGTACCCAGCTCCTAGCAA-30
ncRNAR 50-CCAGAGAGCAACAGGCATCA-30
GAPDHRTF 50-ACCTGCCAAATATGATGAC-30
GAPDHRTR 50-TCATACCAGGAAATGAGCTT-30
Chromatin IP. For ChIP using various Histone H3 and histone-modification
antibodies we followed Abcam X-ChIP protocol (http://www.abcam.com/
protocols/cross-linking-chromatin-immunoprecipitation-x-chip-protocol)
with slight modifications. Briefly cultured cells were cross-linked with 0.75%
formaldehyde for 10min at room temperature followed by incubation with
125mM of Glycine for 5min. Cells were washed with PBS and sonicated in the
ChIP lysis buffer containing 50mM HEPES-KOH pH 7.5, 140mM NaCl, 1mM
EDTA pH 8, 1% Triton X-1000, 1% Sodium Deoxycholate, 0.1% SDS and protease
inhibitors using Bioruptor (Diagenode). In all, 50 mg of protein supernatant was
taken for each ChIP and diluted 10 times with RIPA buffer (50mM Tris-HCl, pH
8, 150mM NaCl, 2mM EDTA, pH 8, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS and protease inhibitors (added freshly each time)). In all, 2 mg of the respective
antibodies (5mg for dimethyl arginine) were added to the respective samples and
binding was done overnight. Twenty microliters of protein A/G (Santa Cruz) or
protein-A magnetic beads (Diagenode) were added for 3 h. The beads were washed
3 times with wash buffer (0.1% SDS, 1% triton-X-100, 2mM EDTA, pH 8, 150mM
NaCl, 20mM Tris-HCl, pH 8)and once with final wash buffer (0.1% SDS, 1%
triton-X-100, 2mM EDTA, pH 8, 500mM NaCl, 20mM Tris-HCl, pH 8).
The chromatin was eluted by adding 120ml of elution buffer (1% SDS and 100mM
NaHCO3) and reverse cross linked by using Proteinase K at 65C for 4 h. The DNA
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was extracted by phenol:chloroform and ethanol precipitation (in presence of
glycogen) followed by real-time qPCR using the following primers:
NOXA1chipF 50-CATCGGGGCCTCAGTTTC-30
NOXA1chipR 50-GCGCCGGATAAAGCCCT-30
NOX1chipF 50-CACGCTTCCCTCCCTACTTC-30
NOX1chipR 50-AGGGTTTTACCTGTGGGGAT-30
NOX4chipF 50-GAGGAAGGGTGGGAGAAACG-30
NOX4chipR 50-CCAGGCTCCAAAATACTGGC-30
NOS2chipF 50-TAAAACCTGGCTCCGTGGTG-30
NOS2chipR 50-TTTCCAAAGGGAGTGTCCCC-30
TNFAIP2chipF 50-GTCCCCCGAACTCCACATAC-30
TNFAIP2chipR 50-GCAAGGCCTGAAATAGTCGC-30
TRAF3chipF 50-CCAGCCAGGACAGCGTATTT-30
TRAF3chipR 50-GTTAGAGGCGACTGCCTGAG-30
CDCBPBchipF 50-CGGACCCCGAATACTGAAG-30
CDCBPBchipR 50-GTAGGGAGCCGGGATGCT-30
ncRNAchipF 50-AATGAGCACCCTGTCCAAAT-30
ncRNAchipR 50-CTCCCAGAGGACAAAAGCAG-30
RegionBchipF 50-ACGAGGTCAGGAGTTCGAGA-30
RegionBchipR 50-TGAGCCATAGCGCCTGTAAT-30
RegionCchipF 50-AGGTACCCAGCTCCTAGCAA-30
RegionCchipR 50-TGCCCATGACCTTCATTCCA-30
LUCchipF 50-CCGAGTTTCTAGACGGAGTACTGT-30
LUCchipR 50-CCCACCCCCTTTTATAGCC-30
Each experiment was done in duplicates and repeated with three biological
replicates.
Antibodies. GroEL1 antibody was a kind gift from Dr Shekhar Mande, NCCS,
Pune, India. H3 (ab1791), H3K4me3 (ab8580), H3K9me3 (ab8898), H3K27me3
(ab6002), dimethyl arginine (ab413), His (ab9108) and GAPDH (ab22555)
antibodies were purchased from Abcam. The Flag antibody was purchased from
Sigma (F1804). H3 antibody was purchased from Millipore (07-690). The speci-
ficity of 6XHis antibody was checked by western blotting (Supplementary Fig. 15).
H3R42me2 antibody was raised against the R42 peptide ‘KPHR*YRPGTVALRC’
from histone H3, where R* corresponds to arginine R42 in H3 and was dime-
thylated asymmetrically (Abgenex, India). The specificity of the purified antibody
(see next section for purification details) was confirmed by peptide competition
assay (Supplementary Fig. 13). Briefly, different concentrations of recombinant
histone H3 incubated with 2 mg Rv1988 in presence of cold SAM were electro-
phoresed on an SDS–polyacrylamide gel electrophoresis. One set was probed with
H3R42me2 antibody pre-incubated with the methylated R42 peptide and other set
was probed with H3R42me2 pre-incubated with the unmodified R42 peptide. The
peptide concentration used for competition was 1:3 (1 mg of antibody with 3 mg of
peptide). The antibody was used at a dilution of 1:2,500 for 3 h at room
temperature in western blotting. Antibodies against dimethyl arginine (as used in
Fig. 5c), as well as histone modifications (with the exception of H3R42me2) were
used at 2 mg per ChIP reaction. Apart from Fig. 5c, in all other experiments,
dimethyl arginine antibody was used at 5 mg per ChIP reaction. H3R42me2 and
6XHis antibodies were used at 3 mg per ChIP reaction. For western blots, the
various antibodies were used at the following dilutions: anti-FLAG—1:5,000,
anti-H3—1:4,000, anti-dimethyl arginine—1:2,500, anti-Rv1988—1:2,500, anti
6XHis—1:4,000, anti GAPDH—1:5,000 and anti H3R42me2—1:4,000.
Purification of H3R42me2 antibody. Peptides used for antibody generation:
Control peptide KPHRYRPGTVALRC
Modified peptide KPHR*YRPGTVALRC (R* asymmetric dimethylation)
Approximately, 10–12ml of selected serum was taken and filtered through a
Whatman filter paper. Filtered serum was then diluted with PBS in 1:1 ratio. This
was mixed with non-dimethylated peptide-conjugated matrix (sulfo-link) and
column was incubated on a shaker for 4 h at 25C. This step was carried out to
remove all the non-dimethylated specific antibody. After the binding of antibody,
column was washed with six-column volume of PBS to wash away non-bound
components of the sample solution. The flow-through was saved for purification
of antibody against di-methyl peptide and was mixed with di-methyl peptide-
conjugated matrix (sulfo-link) and column was incubated on shaker for overnight
at 4C. After the binding of antibody, column was washed with six-column volume
of PBS to wash away non-bound components of the sample solution. Protein was
eluted by passing desired amount of elution buffer (0.1M glycine, pH 2.7) through
the column. Separate 1ml fractions were collected, neutralizing each one by prior
adding 100 ml of neutralization buffer (1M Tris-HCl, pH, 8.0, 1.5M NaCl, 1mM
EDTA, 0.5% sodium azide). Eluted fractions of interest were pooled and dialysed
into a one litre PBS with one change for overnight or the downstream application.
Concentration was measured and ELISA was performed on each antibody so as to
verify each lot.
Uncropped scans for the gels using H3R42me2 antibody are shown in
Supplementary Fig. 16.
Identification of Rv1988-bound regions from HEK293 cells. HEK293 cells
transfected with pCDNA-SFB-1988 or pCDNA-SFB were processed as mentioned
above in the ChIP protocol. First pull-down was done with Streptavidin beads and
enriched fraction was incubated with S-protein-binding beads. The enriched DNA
was end-repaired using Klenow fragment (NEB), adaptor ligated with the following
annealed adaptors LK102 50-GCGGTGACCCGGGAGATCTGAATTC-30 and
LK103 50-GAATTCAGATC-30 (Nimblegen Systems) PCR was performed using
LK102 adaptor as primer with high fidelity Phusion High fidelity DNA Polymerase
(Finnzymes). The PCR reaction was resolved on 1.5% agarose gel. Observed
differentially amplified band was cut and eluted. The DNA was digested with EcoRI
enzyme (NEB) and ligated in EcoRI digested pbSK vector (Stratagene). After
transformation individual colonies were screened and positive clones were
sequenced (Supplementary Fig. 8).
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